United States · FDA National Drug Code directory
Natesto nasal gel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42667-5511_1ed05dab-581e-42da-aafc-26c3a759e9ac
- Product NDC
- 42667-5511
- Form
- GEL, METERED
- Composition / generic term
- testosterone
- Labeler
- Acerus Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200508
- Source listing expiry
- 20271231
Source-listed ingredients
- TESTOSTERONE — 5.5 mg/.122g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR · 42667-5511-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →